EurekAlert!, a service of AAAS
Home About us
Advanced Search
17-Apr-2014 11:28
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Science Business News

Key: Meeting M      Journal J      Funder F

Showing releases 101-125 out of 132.

<< < 1 | 2 | 3 | 4 | 5 | 6 > >>

Public Release: 17-Mar-2014
Ohio State partners with MedVax Technologies Inc. to bring a cancer peptide vaccine to patients
The Ohio State University, through the Ohio State Innovation Foundation, has signed an exclusive world-wide licensing agreement with MedVax Technologies Inc. for the licensing of groundbreaking cancer peptide vaccine technologies.
NIH/National Cancer Institute

Contact: Amanda J Harper
amanda.harper2@osumc.edu
614-685-5420
Ohio State University Wexner Medical Center

Public Release: 14-Mar-2014
IceBridge starts with sea ice surveys
NASA's Operation IceBridge started the 2014 Arctic campaign with two surveys of sea ice north of Greenland. The two flights follow similar surveys flow in previous years and continue the mission's goals of collecting data on changing sea ice in the Arctic.
NASA

Contact: George Hale
George.r.hale@nasa.gov
301-614-5853
NASA/Goddard Space Flight Center

Public Release: 14-Mar-2014
New strategic plan guides NSF through 2018
The National Science Foundation has released a new strategic plan in concert with the President's Budget Request to Congress for NSF in fiscal year 2015. The plan, titled, 'Investing in Science, Engineering and Education for the Nation's Future,' sets goals to guide the agency through 2018.

Contact: Maria C. Zacharias
mzachari@nsf.gov
703-292-8454
National Science Foundation

Public Release: 14-Mar-2014
Menopause International re-launching as Post Reproductive Health
Leading SAGE medical journal, Menopause International, the flagship journal of the British Menopause Society, is expanding its scope and changing its name to Post Reproductive Health from March 2014.

Contact: Katie Baker
020-732-48719
SAGE Publications

Public Release: 13-Mar-2014
Project MERCCURI 'crowdsourced' space station samples take flight
The Microbial Ecology Research Combining Citizen and University Researchers on the International Space Station project (Project MERCCURI) is a crowdsourced effort to send a litany of microbes to the space station for research.

Contact: Laura Niles
Laura.E.Niles@nasa.gov
281-244-7069
NASA/Johnson Space Center

Public Release: 13-Mar-2014
MD Anderson, MedImmune join forces to advance cancer immunotherapy
The University of Texas MD Anderson Cancer Center and MedImmune, the global biologics research and development arm of AstraZeneca, will collaborate through MD Anderson's Moon Shots Program to develop therapies that unleash patients' immune systems to attack their cancers. MD Anderson will evaluate several of MedImmune's immunotherapy molecules in a clinical setting in order to better understand how these molecules elicit immune response in patients.

Contact: Scott Merville
smerville@mdanderson.org
713-792-0661
University of Texas M. D. Anderson Cancer Center

Public Release: 13-Mar-2014
Stem cell therapy may help severe congestive heart failure
Researchers want to know whether patients with debilitating heart failure can benefit by having their own stem cells injected into their ailing heart muscle. Unlike most clinical trials, Berman notes that if this study results are positive, participants who received placebo can also get ixmyelocel-T.

Contact: Toni Baker
tbaker@gru.edu
706-721-4421
Medical College of Georgia at Georgia Regents University

Public Release: 13-Mar-2014
Virtual lab for nuclear waste repository research
A nuclear waste repository must seal in radioactive waste safely for one million years. Researchers currently have to study them and their processes in real underground laboratories but a virtual underground laboratory will soon simplify their work.

Contact: Dipl.-Ing. Steffen Masik
steffen.masik@iff.fraunhofer.de
49-391-409-0127
Fraunhofer-Gesellschaft

Public Release: 13-Mar-2014
CeBIT
TUD professor Gerhard Fettweis presents 'tactile internet' at CeBIT
The coordinator of the Center for Advancing Electronics Dresden, professor Gerhard Fettweis, is heading a common initiative by German research institutes and industrial companies presented at the German computer fair CeBIT in Hannover on March 10, 2014. Globally, multi-billion amounts are invested in this area of research -- e.g., by the notion of fifth generation of mobile communications.

Contact: Birgit Holthaus
birgit.holthaus@tu-dresden.de
49-351-463-42848
Technische Universität Dresden

Public Release: 12-Mar-2014
Ground validation: Contributing to Earth observations from space
With GPM, scientists will gather vast amounts of precipitation data on a global scale. But, how do they know how to interpret the data? This is where ground validation contributes to the mission. Using instruments that complement and correlate with those on the spacecraft, scientists on the ground gather similar precipitation data.
NASA, Japan Aerospace Exploration Agency

Contact: Ellen Gray
Ellen.t.gray@nasa.gov
301-286-1950
NASA/Goddard Space Flight Center

Public Release: 12-Mar-2014
Microbes in space
Microbes collected from Northern California and throughout the nation will soon blast into orbit for research and a microgravity growth competition on the International Space Station. This citizen science research, known as Project MERCCURI, investigates how microbes from different places on Earth compare to each other and to those found on the International Space Station.

Contact: Carole Gan
carole.gan@ucdmc.ucdavis.edu
916-765-2304
University of California - Davis Health System

Public Release: 12-Mar-2014
FASEB releases best practices guide on mitigating the risk from animal rights extremism
The Federation of American Societies for Experimental Biology released a best practices guide designed to aid individuals and organizations in reducing the threat posed by animal rights extremists.

Contact: Lawrence Green
lgreen@faseb.org
301-634-7335
Federation of American Societies for Experimental Biology

Public Release: 12-Mar-2014
New bilateral pilot opportunity will fund collaborations between US and UK bioscience researchers
A new, two-year pilot opportunity -- known as the US NSF/BIO-UK BBSRC Lead Agency Pilot Opportunity -- is being formally launched today.

Contact: Lily Whiteman
lwhitema@nsf.gov
703-292-8310
National Science Foundation

Public Release: 12-Mar-2014
National Science Foundation presents FY 2015 budget request
The FY15 Budget Request for NSF of $7.3 billion supports investments in fundamental research across all scientific disciplines, engineering and education that continue to enhance our national economy, security and quality of life. The budget request represents an increase of about 1 percent over the FY 2014 appropriation of $7.2 billion.

Contact: Maria C. Zacharias
mzachari@nsf.gov
703-292-8454
National Science Foundation

Public Release: 12-Mar-2014
AZTI-Tecnalia develops a methodology for authenticating canned tuna species within 24 hours
AZTI-Tecnalia, the R&D center based on marine and food research, has developed a new method to authenticate canned tuna, which allows you to check if a product is albacore tuna, yellowfin or bigeye tuna, and others tuna species within 24 hours. The DNA system developed by the Molecular Biology Laboratory at AZTI-Tecnalia for detecting various species of canned and processed tuna, has received accreditation from the National Accreditation Body.

Contact: Irati Kortabitarte
i.kortabitarte@elhuyar.com
34-943-363-040
Elhuyar Fundazioa

Public Release: 12-Mar-2014
EMBO Molecular Medicine
Tuberculosis -- EPFL creates a foundation to launch an antibiotic
Researchers have discovered an promising antibiotic for tuberculosis. In an article published in EMBO Molecular medicine, the researchers show that, when combined with other drugs, the new antibiotic can take down even the most resistant strains. Following the publication, the researchers formed the IM4TB Foundation on their campus. The foundation aims to bring the treatment to the market. This unusual step was taken because with tuberculosis, development costs are too high.
European Commission

Contact: Lionel Pousaz
lionel.pousaz@epfl.ch
41-795-597-161
Ecole Polytechnique Fédérale de Lausanne

Public Release: 11-Mar-2014
Rowan University Foundation creates new venture fund, commits $5 million
The Rowan University Foundation, the philanthropic and fundraising arm of Rowan University, committed to allocate $5 million to a new venture capital fund to fuel new research initiatives by faculty, students and alumni.
Rowan University Foundation

Contact: Patricia Quigley
quigley@rowan.edu
856-256-4241
Rowan University

Public Release: 11-Mar-2014
Microbe growth to be examined at International Space Station for UC Davis research project
Microbes collected across the country will soon blast into orbit for research and a microgravity growth competition on the International Space Station. This citizen science research, known as Project MERCCURI, investigates how microbes from different places on Earth compare to each other and to those found on the International Space Station.

Contact: Claire LaBeaux
Claire@prclaire.com
925-337-0244
Project MERCCURI

Public Release: 11-Mar-2014
NREL aims to improve building energy performance with new web-based tool
The Energy Department's National Renewable Energy Laboratory has developed a web-based tool to help consumers better understand the energy performance of building-related products. The Technology Performance Exchange is a portal that helps manufacturers and other organizations that measure and test products easily share performance data with product consumers.
US Department of Energy

Contact: David Glickson
david.glickson@nrel.gov
303-275-4097
DOE/National Renewable Energy Laboratory

Public Release: 11-Mar-2014
GENETHON and ESTEVE announce agreement to manufacture the gene therapy for the treatment of Sanfilippo syndrome
ESTEVE, a Spanish pharmaceutical company devoted to the research, development, manufacturing and commercialization of novel medicines and Genethon, a non‐profit organization dedicated to the research and development of gene therapies for orphan genetic diseases, announce that they have entered into an agreement to manufacture Esteve's investigational gene therapy for the treatment of Sanfilippo A Syndrome, AAV9-hsulfamidase, under GMP.
ESTEVE

Contact: Press Office
presse@afm.genethon.fr
AFM-Téléthon

Public Release: 11-Mar-2014
Revolutionary nuclear radiation detector hits the market
A handheld radiation camera developed by University of Michigan engineering researchers offers nuclear plant operators a faster way to find potentially dangerous hot spots and leaky fuel rods.

Contact: Kate McAlpine
kmca@umich.edu
734-763-4386
University of Michigan

Public Release: 11-Mar-2014
Industry, academic researchers gather for Accelerating Cancer Cures Research Symposium
Today, the Damon Runyon Cancer Research Foundation held the third annual Accelerating Cancer Cures Research Symposium. The yearly meeting is designed to encourage collaboration between cancer researchers in industry and their counterparts in academia in order to sidestep many of the issues that currently impede progress against cancer. Hosted by Genentech, the meeting included academic researchers from top universities and research institutions as well as scientists from Eli Lilly and Company, Celgene, Merck, Pfizer, and Takeda Pharmaceuticals International Co.

Contact: Yung Lie
yung.lie@damonrunyon.org
212-455-0521
Damon Runyon Cancer Research Foundation

Public Release: 11-Mar-2014
ESTEVE and UAB advance in their program to develop a cure for Sanfilippo A syndrome
ESTEVE has announced the signing of two agreements that will enable it to progress the development of its gene therapy for the treatment of Mucopolysaccharidosis type IIIA (MPSIIIA or Sanfilippo A Syndrome) and begin a phase I/II clinical trial in 2015. This gene therapy program is being developed in a public-private partnership between ESTEVE and the research team of Fatima Bosch at the Universitat Autonoma de Barcelona CBATEG center.

Contact: M. Angels Valls
avalls@esteve.es
34-934-466-286
Universitat Autonoma de Barcelona

Public Release: 11-Mar-2014
Novel vaccine trial design aims to answer key TB questions
Aeras today announced the initiation of the first randomized, controlled tuberculosis vaccine trial designed to study prevention of Mycobacterium tuberculosis infection by vaccination.

Contact: Annmarie Leadman
aleadman@aeras.org
240-599-3018
Aeras

Public Release: 10-Mar-2014
International Space station to beam video via laser back to Earth
A team at NASA's Jet Propulsion Lab in Pasadena, Calif., led the development of the Optical Payload for Lasercomm Science investigation, NASA's first optical communication experiment from the space station, which launches March 16 aboard SpaceX-3.

Contact: Laura Niles
Laura.E.Niles@nasa.gov
281-244-7069
NASA/Johnson Space Center

Showing releases 101-125 out of 132.

<< < 1 | 2 | 3 | 4 | 5 | 6 > >>